|Mr. Timothy George Dixon||Chairman, CEO & Pres||220k||N/A||1958|
|Dr. Feng Lin||Chief Scientific Officer||N/A||N/A||1969|
|Dr. James Drew Veltmeyer M.D.||Chief Medical Officer, Vice Chairman of CTE Advisory Board & Member of Scientific Advisory Board||N/A||N/A||1964|
|Ms. Serena Robella||Director of Sales||N/A||N/A||N/A|
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to target cancers, improve maternal and fetal health, and fight periodontal disease, as well as for daily health. Its flagship products include NanoStilbene, an easily absorbed nanoemulsion of nanoparticle pterostilbene to reduce inflammatory cytokine production in cancer patients; and ProJuvenol, a synergistic blend of complex anti-aging ingredients. The company also focuses on the manufacture of devices to treat patients with obstructive sleep apnea. Therapeutic Solutions International, Inc. is based in Elk City, Idaho.
Therapeutic Solutions International, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.